ANALYSIS: HYPERTENSION DRUGS SOAR IN CHINA

Sales of drugs to treat hypertension in China will nearly double from the current level of $440 million to $800 million in 2010, according to projections from an analyst report released Tuesday. UPI (http://www.upi.com/HealthBusiness/view.php?StoryID=20061010-051109-7727r)